Analysts ponder F&P Healthcare in a post-Covid world
F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.
AdvertisementAdvertise with NZME.
Latest from Fisher and Paykel Healthcare
Liam Dann: Despite vaccine news, war is far from over
Vaccine is no silver bullet but at least brings the horizons of this crisis into focus.
Market close: NZ shares end firmer, while FPH and a2 Milk ease
Trade thinned out before the long Labour Day weekend.
F&P Healthcare's huge earnings upgrade - is there more to come?
Could F&P Healthcare's earnings upgrade be too conservative?
F&P Healthcare stock rallies sharply on earnings update
F&P Healthcare said Covid-19 demand would drive earnings sharply higher in 2021.
NZ corporate earnings are in a state of flux
The re-emergency of Covid-19 has cast more doubt on NZ corporate earnings.
Sharemarket drops sharply on fresh Covid cases, Auckland lockdown
Kiwi dollar steady but shares take a hit.
Oliver Mander: Robust returns for F&P Healthcare shareholders
Innovative company has looked after the health of its customers -- and its investors.
Fisher & Paykel Healthcare on hiring spree
F&P Healthcare has hired some 600 additional direct manufacturing staff locally.
F&P Healthcare delivers another record profit, but is it sustainable?
F&P Healthcare has delivered another record profit, but is its growth sustainable?
F&P Healthcare shares spike after profit hits record
The company's net profit is tipped to grow even more next year.
Airfreight exports of NZ respiratory products boomed in March - AIA
Airfreighted exports of respiratory products shot higher in March, AIA says.
Continuous Disclosure: Why investors are lining up for NZ recapitalisation plans
Plus, is Sky City next in line to raise capital?
Continuous Disclosure: Sharemarket's biggest company keeps going up
Plus, Heartland shareholders still waiting for clarity.
F&P Healthcare shares rally sharply after earnings upgrade
F&P Healthcare's respiratory products are used in treating patients with coronavirus.
F&P Healthcare shares spike after earnings upgrade
Firm expects full year operating revenue to be $1.17b for net profit of about $245m-$255m.
'Colour Your Day' movement takes off after mosque shootings
Initiative aims to lift New Zealanders' spirits on Friday.
F&P Healthcare shares rally after deal with arch-rival
The fight has cost millions of dollars and spanned the globe.
F&P Healthcare hits record interim profit of $97.4 million
Net profit rose 20 per cent from a year ago.
F&P Healthcare to take $5-10M hit in patent stoush
Fisher & Paykel Healthcare is going toe to toe with rival ResMed.
Market has priced FPH at perfection, say analysts
Shares in Fisher & Paykel Healthcare fell slightly, despite another record result.
F&P Healthcare posts record result, nears $1 billion revenue
Fisher & Paykel Healthcare has posted another record result
F&P Healthcare boosts profits
Annual profit is likely to be between $185 million and $190 million.
F&P Healthcare wins patent case against ResMed
F&P Healthcare wins patent case against ResMed in UK Court.
Soaring Kiwi tech sector tops $10b of revenue: report
NZ tech companies have recorded over $10 billion in revenue for the first time.
F&P Healthcare may appeal ruling on Resmed
The ruling in Germany says ResMed did not infringe its patents.
Mercury leads sharemarket higher
NZ Refining stock falls amid pipeline repiar, while Synlait retreats from high.
F&P Healthcare lowers guidance on strong NZD
Fisher & Paykel Healthcare lowered full year earnings guidance due to the strong NZ dollar
F&P Healthcare boss sells shares to buy house
Lewis Gradon sold almost half of his shares, raising about $3.1 million to buy a house.
Embracing governance issues
COMMENT: Companies with higher ESG ratings are, on average, outperforming their peers.